Vivani Medical Inc（VANI）财务数据VANIVivani Medical Inc

Evaluating the bottom line, Vivani Medical Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -220.40%, provide a clear picture of how effectively VANI converts its operational activities into shareholder value.

In the context of the broader market, VANI competes directly with industry leaders such as NRXP and VTVT. With a market capitalization of $93.81M, it holds a significant position in the sector. When comparing efficiency, VANI's gross margin of N/A stands against NRXP's 32.70% and VTVT's 100.00%. Such benchmarking helps identify whether Vivani Medical Inc is trading at a premium or discount relative to its financial performance.

Vivani Medical has been experiencing significant financial losses, with a net income of -6,780,000 USD in Q1 2026 and a gross profit of 0 USD in Q4 2024. The company's return on equity (ROE) is also negative, reaching -220.40% in Q2 2026, indicating poor profitability.